Good news! As submission to SI Medicina MDPI are rolling in & many colleagues asked for more time, we are glad to announce a deadline extension to submit your paper about #LiverTransplantation & #regeneration 📅 30 April 2023. Save the date! 🔗mdpi.com/journal/medici… RT, please!

Happy to have successfully performed the first liver transplant from a centenarian donor. This transplant is the last step of a long path during which we learned how to select donors, appropriately match them to the right recipient and properly use technology.

A new paradigm for the safe utilization of “high risk” uncontrolled DCD donors for liver transplantation: the role of “double check approach” with NRP and ex-situ normothermic perfusion.

Hot-off the press: our paper in Nature Biotech “𝙇𝙤𝙣𝙜-𝙩𝙚𝙧𝙢 𝙥𝙧𝙚𝙨𝙚𝙧𝙫𝙖𝙩𝙞𝙤𝙣 𝙤𝙛 𝙡𝙞𝙫𝙚𝙧 𝙜𝙧𝙖𝙛𝙩𝙨 𝙗𝙧𝙞𝙣𝙜𝙨 ‘𝙤𝙛𝙛-𝙩𝙝𝙚-𝙨𝙝𝙚𝙡𝙛’ 𝙤𝙧𝙜𝙖𝙣𝙨 𝙘𝙡𝙤𝙨𝙚𝙧“ #MachinePerfusion Davide Ghinolfi ILTS Liver/Intestinal Community of Practice - AST Transplant Regenerative Medicine COP - AST ASTS IHPBA

The role of sequential #Normothermic regional #Perfusion and end-ischemic normothermic machine perfusion in #LiverTransplantation from very extended uncontrolled #Donation after cardiocirculatory death #OnlineFirst👉bit.ly/3GsFV0T Università di Pisa🇮🇹| Davide Ghinolfi #ExSitu

Happy to share the National Transplant Authority preliminary data: Pisa became the largest liver transplant center in Italy with 148 cases in 2022. Emanuele Balzano Fabio Melandro

Happy to introduce the first basic science paper of the DCDNet Study. Congratulations to Giuseppina, Serena, Francesco, Fabio and the whole team for this important achievement and for all the others coming… #livertransplantation

Convegno ❞𝙍𝙞𝙘𝙚𝙧𝙘𝙖 𝙚 𝙏𝙧𝙖𝙥𝙞𝙖𝙣𝙩𝙤 ❞ Sabato 20 Maggio 2023 ore 9.30! In collaborazione e sinergia con Vite Odv (Volontariato Italiano Trapiantati Epatici, Rene e Pancreas – Organizzazione di Volontariato). A breve maggiori dettagli. #PSC #RareDisease #LiverTwitter

Supporto alle famiglie e alla natalità, per combattere l'inverno/inferno demografico. Se ne parla nel podcast open.spotify.com/episode/4ZpYyF… Tommaso Foti Giulio Centemero Alberto Bagnai Maurizio Leo Alessandro Iodice

Happy to introduce the “Basic science and translational research session: treatment of the liver grafts during machine perfusion” at the ILTS meeting in Rotterdam.

Less than 2 weeks for the ILTS meeting. I will be speaking at the session “𝗧𝗿𝗲𝗮𝘁𝗺𝗲𝗻𝘁 𝗼𝗳 𝗟𝗶𝘃𝗲𝗿 𝗚𝗿𝗮𝗳𝘁𝘀 𝗱𝘂𝗿𝗶𝗻𝗴 𝗠𝗮𝗰𝗵𝗶𝗻𝗲 𝗣𝗲𝗿𝗳𝘂𝘀𝗶𝗼𝗻” Together with Markus Selzner Davide Ghinolfi Fotios Sampaziotis And chaired by kimOLT Dr. Sofia Ferreira

Il 20 Maggio tutti a Viareggio! La ricerca ha bisogno di tutti.

Convegno Ricerca e Trapianto Intervento del Dott Davide Ghinolfi - Stato dell’arte sulle Colangiopatie. Aircs ODVAssociazione VITE #colangiteaclerosanteprimitiva #traianto #PSC #LiverTwitter

Happy to share our study comparing uncontrolled vs controlled DCD using sequential NRP and ex-situ perfusion. New insights on how to evaluate liver grafts during NRP. On Liver Transplantation! DCDNet study DamianoPatrono Riccardo De Carlis Regione Toscana AOUP / Azienda ospedaliero-universitaria pisana Liver Transplantation Journal (LTxJournal)

Proud to announce that “Liver Transplantation “ has chosen our paper for this month cover. “An extensive evaluation of hepatic markers of damage and regeneration in controlled and uncontrolled donation after circulatory death”. The DCDNet Study group in the spotlight !

Happy to introduce next ESOT webinar

Prof Gabriel Oniscu Thank you to our amazing speakers Davide Ghinolfi Prof Gabriel Oniscu Jeroen de Jonge Marius Berman and Corinne Antoine. A great #ESOTcongress last webinar! 👉A special call-out to those eager to partake in the Hands-on courses in Athens – these spots are limited and filling up

notizie.virgilio.it/le-tasse-per-i… In sintesi: l'abrogazione di fatto delle norme del DL crescita è una pessima idea, le modalità proposte ancora peggio. Fermiamoci e ripensiamole Giulio Centemero Tommaso Foti Quirinale toni ricciardi Simone Billi

Il 21 settembre alla Camera di Commercio di Pisa si svolgerà l’evento scientifico “3000 volte Si!”. Parleremo di trapianto di fegato, macchine da perfusione, chirurgia epatobiliare, innovazione, ricerca e tanto altro. Iscrizioni gratuite su planning.it